With the implementation of HCV screening in blood banks, there was a significant reduction in the risk of posttransfusion hepatitis C. Currently, injection drug users are at the highest risk for this infection and are potential sources of transmission to the population at large.
Con la implementación del triaje del HCV en bancos de sangre, se redujo significativamente el riesgo de hepatitis C postransfusional.
Com a implementação da triagem do HCV em bancos de sangue, reduziu-se significativamente o risco de hepatite C pós-transfusional.